CA2280931A1 - Dispositif osteogeniques sans matrice, implants et methodes d'utilisation associees - Google Patents

Dispositif osteogeniques sans matrice, implants et methodes d'utilisation associees Download PDF

Info

Publication number
CA2280931A1
CA2280931A1 CA002280931A CA2280931A CA2280931A1 CA 2280931 A1 CA2280931 A1 CA 2280931A1 CA 002280931 A CA002280931 A CA 002280931A CA 2280931 A CA2280931 A CA 2280931A CA 2280931 A1 CA2280931 A1 CA 2280931A1
Authority
CA
Canada
Prior art keywords
methods
implants
matrix
osteogenic devices
bone formation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002280931A
Other languages
English (en)
Other versions
CA2280931C (fr
Inventor
David C. Rueger
Marjorie M. Tucker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MARIEL THERAPEUTICS Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26714038&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA2280931(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Individual filed Critical Individual
Publication of CA2280931A1 publication Critical patent/CA2280931A1/fr
Application granted granted Critical
Publication of CA2280931C publication Critical patent/CA2280931C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1875—Bone morphogenic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/02—Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Transplantation (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Organic Chemistry (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
CA002280931A 1997-02-07 1998-02-05 Dispositif osteogeniques sans matrice, implants et methodes d'utilisation associees Expired - Fee Related CA2280931C (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US3732797P 1997-02-07 1997-02-07
US60/037,327 1997-02-07
US4790997P 1997-05-29 1997-05-29
US60/047,909 1997-05-29
PCT/US1998/002159 WO1998034655A1 (fr) 1997-02-07 1998-02-05 Dispositif osteogeniques sans matrice, implants et methodes d'utilisation associees

Publications (2)

Publication Number Publication Date
CA2280931A1 true CA2280931A1 (fr) 1998-08-13
CA2280931C CA2280931C (fr) 2009-05-05

Family

ID=26714038

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002280931A Expired - Fee Related CA2280931C (fr) 1997-02-07 1998-02-05 Dispositif osteogeniques sans matrice, implants et methodes d'utilisation associees

Country Status (8)

Country Link
US (2) US6281195B1 (fr)
EP (3) EP2332564A1 (fr)
JP (4) JP4388602B2 (fr)
AT (1) ATE239514T1 (fr)
AU (1) AU6267798A (fr)
CA (1) CA2280931C (fr)
DE (1) DE69814352T3 (fr)
WO (1) WO1998034655A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7902172B2 (en) 1996-03-05 2011-03-08 Depuy Spine, Inc. Method of promoting bone growth with hyaluronic acid and growth factors

Families Citing this family (150)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6586388B2 (en) 1988-04-08 2003-07-01 Stryker Corporation Method of using recombinant osteogenic protein to repair bone or cartilage defects
US6919308B2 (en) * 1988-04-08 2005-07-19 Stryker Corporation Osteogenic devices
US20070166353A1 (en) * 1988-04-08 2007-07-19 Stryker Corporation Osteogenic proteins
EP1225225A3 (fr) * 1988-04-08 2003-01-08 Stryker Corporation Dispositifs ostéogéniques
US6077823A (en) * 1991-03-11 2000-06-20 Creative Biomolecules, Inc. Method for reducing tissue damage associated with ischemia-reperfusion or hypoxia injury
US7056882B2 (en) * 1991-03-11 2006-06-06 Curis, Inc. Treatment to prevent loss of and/or increase bone mass in metabolic bone diseases
US6495513B1 (en) * 1991-03-11 2002-12-17 Curis, Inc. Morphogen-enhanced survival and repair of neural cells
US20080233170A1 (en) * 1992-02-21 2008-09-25 Stryker Corporation Osteogenic Proteins
US8617242B2 (en) 2001-05-25 2013-12-31 Conformis, Inc. Implant device and method for manufacture
US8083745B2 (en) 2001-05-25 2011-12-27 Conformis, Inc. Surgical tools for arthroplasty
US7534263B2 (en) 2001-05-25 2009-05-19 Conformis, Inc. Surgical tools facilitating increased accuracy, speed and simplicity in performing joint arthroplasty
US8234097B2 (en) 2001-05-25 2012-07-31 Conformis, Inc. Automated systems for manufacturing patient-specific orthopedic implants and instrumentation
US8556983B2 (en) 2001-05-25 2013-10-15 Conformis, Inc. Patient-adapted and improved orthopedic implants, designs and related tools
US9603711B2 (en) 2001-05-25 2017-03-28 Conformis, Inc. Patient-adapted and improved articular implants, designs and related guide tools
US8480754B2 (en) 2001-05-25 2013-07-09 Conformis, Inc. Patient-adapted and improved articular implants, designs and related guide tools
US8545569B2 (en) 2001-05-25 2013-10-01 Conformis, Inc. Patient selectable knee arthroplasty devices
US7468075B2 (en) 2001-05-25 2008-12-23 Conformis, Inc. Methods and compositions for articular repair
US8882847B2 (en) 2001-05-25 2014-11-11 Conformis, Inc. Patient selectable knee joint arthroplasty devices
US8771365B2 (en) 2009-02-25 2014-07-08 Conformis, Inc. Patient-adapted and improved orthopedic implants, designs, and related tools
US8735773B2 (en) 2007-02-14 2014-05-27 Conformis, Inc. Implant device and method for manufacture
US7618451B2 (en) 2001-05-25 2009-11-17 Conformis, Inc. Patient selectable joint arthroplasty devices and surgical tools facilitating increased accuracy, speed and simplicity in performing total and partial joint arthroplasty
ATE239514T1 (de) * 1997-02-07 2003-05-15 Stryker Corp Matrixlose osteogene vorrichtungen und implantate und verfahren zu deren verwendung
AU1706499A (en) * 1997-12-04 1999-06-16 Curis, Inc. Maintenance of smooth muscle integrity by morphogenic proteins
WO2000035346A2 (fr) 1998-09-14 2000-06-22 Stanford University Estimation de l'etat d'une articulation et prevention de lesions
US7239908B1 (en) 1998-09-14 2007-07-03 The Board Of Trustees Of The Leland Stanford Junior University Assessing the condition of a joint and devising treatment
US7067144B2 (en) * 1998-10-20 2006-06-27 Omeros Corporation Compositions and methods for systemic inhibition of cartilage degradation
JP3786533B2 (ja) * 1998-11-12 2006-06-14 善彦 西村 ペプチド及び骨形成促進剤
US6660717B1 (en) 1998-12-01 2003-12-09 Akzo Nobel, N.V. Folliculogenesis
ES2242600T3 (es) * 1999-02-04 2005-11-16 Sdgi Holdings, Inc. Composiciones de pasta osteogenica y sus usos.
EP2286847A1 (fr) * 1999-10-15 2011-02-23 Genetics Institute, LLC Formulations à base d'acide hyaluronique aux fins de l'administration de proteines osteogenes
ATE414310T1 (de) 2000-09-14 2008-11-15 Univ Leland Stanford Junior Verfahren zur manipulation medizinischer bilder
DE60138116D1 (de) 2000-09-14 2009-05-07 Univ R Beurteilung des zustandes eines gelenkes und planung einer behandlung
US20020114795A1 (en) 2000-12-22 2002-08-22 Thorne Kevin J. Composition and process for bone growth and repair
US9308091B2 (en) 2001-05-25 2016-04-12 Conformis, Inc. Devices and methods for treatment of facet and other joints
US8951260B2 (en) 2001-05-25 2015-02-10 Conformis, Inc. Surgical cutting guide
US8439926B2 (en) 2001-05-25 2013-05-14 Conformis, Inc. Patient selectable joint arthroplasty devices and surgical tools
WO2002096268A2 (fr) 2001-05-25 2002-12-05 Imaging Therapeutics, Inc. Methodes et compositions d'arthroplastie
US7132110B2 (en) * 2001-08-30 2006-11-07 Isotis Orthobiologics, Inc. Tissue repair compositions and methods for their manufacture and use
DE60205937T3 (de) 2001-11-19 2016-01-21 Scil Technology Gmbh Methode zur Herstellung einer homogen beschichtete Vorrichtung mit osteoinduktiven und osteokonduktiven Eigenschaft
WO2003043576A2 (fr) * 2001-11-20 2003-05-30 Depuy Products, Inc. Compositions osteogeniques et chondrogeniques fluentes
CA2471403A1 (fr) * 2001-12-21 2003-07-10 Gensci Orthobiologics, Inc. Glycols de polyalkylene a extremites coiffees et compositions renfermant de tels composes
US7205337B2 (en) * 2001-12-21 2007-04-17 Isotis Orthobiologics, Inc. End-capped polymers and compositions containing such compounds
IL149562A0 (en) * 2002-05-09 2002-11-10 Prochon Ltd Fgf variants and methods for use thereof
CA2486113A1 (fr) * 2002-05-17 2003-12-04 Wyeth Vehicules injectables solides contenant de l'acide hyaluronique pour l'administration de proteines osteogenes
US8227411B2 (en) * 2002-08-20 2012-07-24 BioSurface Engineering Technologies, Incle FGF growth factor analogs
US7598224B2 (en) 2002-08-20 2009-10-06 Biosurface Engineering Technologies, Inc. Dual chain synthetic heparin-binding growth factor analogs
US7166574B2 (en) * 2002-08-20 2007-01-23 Biosurface Engineering Technologies, Inc. Synthetic heparin-binding growth factor analogs
EP1539261B1 (fr) 2002-09-10 2006-04-12 Scil Technology GmbH Implant metallique revetu de proteine osteoinductive sous une teneur d'oxygene reduite
US7074425B2 (en) * 2002-09-26 2006-07-11 Bonewax, Llc Hemostatic compositions and methods
CA2501041A1 (fr) * 2002-10-07 2004-04-22 Conformis, Inc. Implant articulaire par chirurgie non effractive a geometrie tridimensionnelle correspondant aux surfaces articulaires
JP2006505366A (ja) 2002-11-07 2006-02-16 コンフォーミス・インコーポレイテッド 半月板サイズおよび形状の決定および工夫した処置の方法
BE1015258A5 (fr) 2002-12-18 2004-12-07 Dricot Roland Implant osseux.
US7067123B2 (en) 2003-04-29 2006-06-27 Musculoskeletal Transplant Foundation Glue for cartilage repair
US7901457B2 (en) 2003-05-16 2011-03-08 Musculoskeletal Transplant Foundation Cartilage allograft plug
US20050020506A1 (en) * 2003-07-25 2005-01-27 Drapeau Susan J. Crosslinked compositions comprising collagen and demineralized bone matrix, methods of making and methods of use
US7955616B2 (en) * 2003-09-23 2011-06-07 Orthocon, Inc. Absorbable implants and methods for their use in hemostasis and in the treatment of osseous defects
US20080227696A1 (en) * 2005-02-22 2008-09-18 Biosurface Engineering Technologies, Inc. Single branch heparin-binding growth factor analogs
CA2555583A1 (fr) * 2004-02-20 2005-09-09 Biosurface Engineering Technologies, Inc. Modulateur positif de la proteine 2 morphogenique osseuse
US20060194726A1 (en) * 2004-05-25 2006-08-31 Rueger David C Methods of treating cartilage defects
EP1763362B1 (fr) * 2004-05-25 2011-07-06 Stryker Corporation Utilisation d'op-1s pour traiter les anomalies des cartilages
US20120077743A1 (en) * 2004-05-25 2012-03-29 Rueger David C Methods of treating cartilage defects
US20090319045A1 (en) 2004-10-12 2009-12-24 Truncale Katherine G Cancellous constructs, cartilage particles and combinations of cancellous constructs and cartilage particles
US7837740B2 (en) 2007-01-24 2010-11-23 Musculoskeletal Transplant Foundation Two piece cancellous construct for cartilage repair
US7473678B2 (en) * 2004-10-14 2009-01-06 Biomimetic Therapeutics, Inc. Platelet-derived growth factor compositions and methods of use thereof
WO2006047279A2 (fr) * 2004-10-21 2006-05-04 University Of Iowa Research Foundation Systeme d'administration in situ de medicaments a liberation controlee
US7951880B2 (en) * 2004-12-10 2011-05-31 University Of Iowa Research Foundation Compositions for breast implant filling and methods of use
US7270655B2 (en) * 2005-01-14 2007-09-18 Haidukewych George J Autologous material delivery apparatus and method
US20060233849A1 (en) * 2005-04-13 2006-10-19 Simon Bruce J Composite bone graft material
US7621963B2 (en) * 2005-04-13 2009-11-24 Ebi, Llc Composite bone graft material
WO2007001624A2 (fr) * 2005-06-28 2007-01-04 Microchips, Inc. Dispositifs d’implants médicaux et dentaires pour administration contrôlée de médicaments
US7815926B2 (en) 2005-07-11 2010-10-19 Musculoskeletal Transplant Foundation Implant for articular cartilage repair
JP2009508596A (ja) 2005-09-19 2009-03-05 ヒストジェニックス コーポレイション 細胞支持基材及びその調製方法
BRPI0618794A2 (pt) * 2005-11-17 2011-09-13 Biomimetic Therapeutics Inc uso de uma matriz biocompatìvel, kit e composição para aumento ósseo, especialmente para aumento do osso maxilofacial
EP1951158A4 (fr) 2005-11-21 2010-03-31 Vertegen Inc Dispositifs et procédés de traitement de facettes articulaires lombaires, d'articulations uncovertébrales, d'articulations costovertébrales et d'autres articulations
CN105030297A (zh) 2006-02-06 2015-11-11 康复米斯公司 患者可选择的关节成形术装置和手术器具
US8623026B2 (en) 2006-02-06 2014-01-07 Conformis, Inc. Patient selectable joint arthroplasty devices and surgical tools incorporating anatomical relief
ES2427993T3 (es) 2006-02-09 2013-11-05 Biomimetic Therapeutics, Llc Composiciones y métodos para el tratamiento de hueso
US8506983B2 (en) * 2006-05-01 2013-08-13 Warsaw Orthopedic, Inc. Bone filler material
US7771741B2 (en) * 2006-05-01 2010-08-10 Warsaw Orthopedic, Inc Demineralized bone matrix devices
US20100209470A1 (en) * 2006-05-01 2010-08-19 Warsaw Orthopedic, Inc. An Indiana Corporation Demineralized bone matrix devices
US7838022B2 (en) 2006-05-01 2010-11-23 Warsaw Orthopedic, Inc Malleable implants containing demineralized bone matrix
US20090298761A1 (en) * 2006-05-17 2009-12-03 Donald Engelman Methods of treating cartilage defects using a soluble morphogenic protein complex
US7820172B1 (en) 2006-06-01 2010-10-26 Biosurface Engineering Technologies, Inc. Laminin-derived multi-domain peptides
JP2009541358A (ja) 2006-06-22 2009-11-26 バイオサーフェス エンジニアリング テクノロジーズ，インク． 骨形成を強化するためにｂｍｐ−２増幅因子／共活性化因子を送達するための組成物および方法
US9161967B2 (en) 2006-06-30 2015-10-20 Biomimetic Therapeutics, Llc Compositions and methods for treating the vertebral column
WO2008005427A2 (fr) 2006-06-30 2008-01-10 Biomimetic Therapeutics, Inc. Compositions et procédés destinés au traitement de lésions de la coiffe des rotateurs
AU2007275580C1 (en) * 2006-07-21 2012-07-19 University of Zagreb School of Medicine BMP-1 procollagen C-proteinase for diagnosis and treatment of bone and soft tissue defects and disorders
US20060287654A1 (en) * 2006-08-11 2006-12-21 Jeffrey Posnick Implant securing device and method
JP5740087B2 (ja) * 2006-09-13 2015-06-24 エンハンス スキン プロダクツ，インク． スキンケア用化粧品組成物およびその製造方法
AU2007333425B2 (en) 2006-11-03 2014-03-27 Biomimetic Therapeutics, Llc Compositions and methods for arthrodetic procedures
AU2007234612B2 (en) 2006-12-14 2013-06-27 Johnson & Johnson Regenerative Therapeutics, Llc Protein stabilization formulations
CA2671925A1 (fr) * 2006-12-21 2008-07-10 Stryker Corporation Formulations a liberation entretenue comprenant des cristaux, des gels macromoleculaires et des suspensions particulaires d'agents biologiques
US7718616B2 (en) 2006-12-21 2010-05-18 Zimmer Orthobiologics, Inc. Bone growth particles and osteoinductive composition thereof
HUE060822T2 (hu) 2006-12-29 2023-04-28 Ossifi Mab Llc Módszerek a csontnövekedés megváltoztatására SOST vagy WISE antagonista vagy agonista adásával
US20080195476A1 (en) * 2007-02-09 2008-08-14 Marchese Michael A Abandonment remarketing system
WO2008101300A1 (fr) * 2007-02-23 2008-08-28 Cellixe Pty Ltd Composition et méthode de traitement ou de prévention de troubles rachidiens
US8435551B2 (en) 2007-03-06 2013-05-07 Musculoskeletal Transplant Foundation Cancellous construct with support ring for repair of osteochondral defects
AU2008255016B2 (en) * 2007-05-15 2013-05-09 Stryker Corporation Concentrated protein preparations of bone morphogenetic proteins and methods of use thereof
US7678764B2 (en) 2007-06-29 2010-03-16 Johnson & Johnson Regenerative Therapeutics, Llc Protein formulations for use at elevated temperatures
US20090054984A1 (en) 2007-08-20 2009-02-26 Histogenics Corporation Method For Use Of A Double-Structured Tissue Implant For Treatment Of Tissue Defects
US8685107B2 (en) 2007-07-03 2014-04-01 Histogenics Corporation Double-structured tissue implant and a method for preparation and use thereof
JP5323832B2 (ja) 2007-08-07 2013-10-23 アドバンスト・テクノロジーズ・アンド・リジェネレイティブ・メディスン・エルエルシー 酸性水溶液中にｇｄｆ−５を含むタンパク質製剤
US9056150B2 (en) 2007-12-04 2015-06-16 Warsaw Orthopedic, Inc. Compositions for treating bone defects
RU2010137106A (ru) 2008-02-07 2012-03-20 Байомайметик Терапьютикс, Инк. (Us) Композиции и способы для дистракциионного остеогенеза
AU2009221773B2 (en) * 2008-03-05 2015-03-05 Conformis, Inc. Edge-matched articular implant
US8682052B2 (en) 2008-03-05 2014-03-25 Conformis, Inc. Implants for altering wear patterns of articular surfaces
US8840913B2 (en) * 2008-03-27 2014-09-23 Warsaw Orthopedic, Inc. Malleable multi-component implants and materials therefor
US7947649B2 (en) 2008-04-14 2011-05-24 Advanced Technologies And Regenerative Medicine, Llc Liquid buffered GDF-5 formulations
US8338170B2 (en) 2008-04-21 2012-12-25 Viacyte, Inc. Methods for purifying endoderm and pancreatic endoderm cells derived from human embryonic stem cells
DK2993226T3 (da) * 2008-06-03 2021-02-22 Viacyte Inc Vækstfaktorer til fremstilling af en definitiv endoderm
US20090298178A1 (en) * 2008-06-03 2009-12-03 D Amour Kevin Allen Growth factors for production of definitive endoderm
CA2735885C (fr) 2008-09-09 2018-08-28 Biomimetic Therapeutics, Inc. Compositions refermant un facteur de croissance derive des plaquettes et methodes de traitement de blessures de tendons et de ligaments
US8808297B2 (en) 2009-02-24 2014-08-19 Microport Orthopedics Holdings Inc. Orthopedic surgical guide
US8808303B2 (en) 2009-02-24 2014-08-19 Microport Orthopedics Holdings Inc. Orthopedic surgical guide
US9017334B2 (en) 2009-02-24 2015-04-28 Microport Orthopedics Holdings Inc. Patient specific surgical guide locator and mount
EP2419035B1 (fr) 2009-04-16 2017-07-05 ConforMIS, Inc. Méthodes d'arthroplastie articulaire spécifique au patient pour réparation de ligament
ES2702049T3 (es) 2009-04-24 2019-02-27 Univ Vanderbilt Inducción anti-TGF-beta de crecimiento óseo
AU2010327987B2 (en) 2009-12-11 2015-04-02 Conformis, Inc. Patient-specific and patient-engineered orthopedic implants
BR112012020566B1 (pt) 2010-02-22 2021-09-21 Biomimetic Therapeutics, Llc Composição de fator de crescimento derivado de plaqueta
EP2625263B1 (fr) 2010-10-08 2020-03-11 Terumo BCT, Inc. Procédés et systèmes configurables pour la culture et la récolte de cellules dans un système de bioréacteur à fibres creuses
EP2640429B1 (fr) 2010-11-15 2016-12-21 Zimmer Orthobiologics, Inc. Substances de remplissage de vides osseux
US8524662B2 (en) 2010-12-28 2013-09-03 Depuy Mitek, Llc Compositions and methods for treating joints
US8455436B2 (en) 2010-12-28 2013-06-04 Depuy Mitek, Llc Compositions and methods for treating joints
US8398611B2 (en) 2010-12-28 2013-03-19 Depuy Mitek, Inc. Compositions and methods for treating joints
WO2012112698A2 (fr) 2011-02-15 2012-08-23 Conformis, Inc. Implants articulaires adaptés à un patient et améliorés, procédures et outils destinés à déterminer, évaluer, corriger, modifier et/ou s'adapter à une variation et/ou à une asymétrie anatomique
BR112013026241A2 (pt) 2011-04-11 2019-09-24 Induce Biologics Inc sistema e método para liberação multifásica de fatores de crescimento
US8623839B2 (en) 2011-06-30 2014-01-07 Depuy Mitek, Llc Compositions and methods for stabilized polysaccharide formulations
US8992949B1 (en) 2011-11-17 2015-03-31 Unicare Biomedical, Inc. Biocompatible polymeric compositions having microcrystalline and amorphous components and methods for their manufacture
US9486226B2 (en) 2012-04-18 2016-11-08 Conformis, Inc. Tibial guides, tools, and techniques for resecting the tibial plateau
US9675471B2 (en) 2012-06-11 2017-06-13 Conformis, Inc. Devices, techniques and methods for assessing joint spacing, balancing soft tissues and obtaining desired kinematics for joint implant components
ES2971913T3 (es) 2013-03-14 2024-06-10 Osteoqc Inc Derivados de un alquil-amina harmina para la promoción del crecimiento de los huesos
BR112015016264A2 (pt) * 2013-03-14 2017-07-11 Genzyme Corp composições de crescimento ósseo termo-sensível
WO2015073918A1 (fr) 2013-11-16 2015-05-21 Terumo Bct, Inc. Expansion de cellules dans un bioréacteur
EP3122866B1 (fr) 2014-03-25 2019-11-20 Terumo BCT, Inc. Remplacement passif de milieu
EP3198006B1 (fr) 2014-09-26 2021-03-24 Terumo BCT, Inc. Alimentation programmée
US10077420B2 (en) 2014-12-02 2018-09-18 Histogenics Corporation Cell and tissue culture container
CN107847638A (zh) 2014-12-29 2018-03-27 佰欧维恩图斯有限责任公司 用于骨修复中改善骨诱导性分子递送的***和方法
US9682099B2 (en) 2015-01-20 2017-06-20 DePuy Synthes Products, Inc. Compositions and methods for treating joints
WO2016172026A1 (fr) 2015-04-20 2016-10-27 The Board Of Regents Of The University Of Texas System Clec11a en tant qu'agent de croissance osseuse
WO2017004592A1 (fr) 2015-07-02 2017-01-05 Terumo Bct, Inc. Croissance cellulaire à l'aide de stimuli mécaniques
EP3464565A4 (fr) 2016-05-25 2020-01-01 Terumo BCT, Inc. Expansion cellulaire
US11104874B2 (en) 2016-06-07 2021-08-31 Terumo Bct, Inc. Coating a bioreactor
US11685883B2 (en) 2016-06-07 2023-06-27 Terumo Bct, Inc. Methods and systems for coating a cell growth surface
US11624046B2 (en) 2017-03-31 2023-04-11 Terumo Bct, Inc. Cell expansion
EP3656842A1 (fr) 2017-03-31 2020-05-27 Terumo BCT, Inc. Expansion de cellules
TWI727174B (zh) * 2017-05-30 2021-05-11 荷蘭商阿克法Ｉｐ有限公司 新穎的再吸收性生物可降解醫藥及化粧品組合物
US11903949B2 (en) 2018-08-14 2024-02-20 Ossifi Therapeutics Llc Fluoro beta-carboline compounds
MX2021001752A (es) 2018-08-14 2021-06-23 Osteoqc Inc Compuestos de pirrolo-dipiridina.
US11324806B2 (en) 2018-10-19 2022-05-10 Warsaw Orthopedic, Inc. Sustained delivery of a growth differentiation factor
US20220098310A1 (en) 2018-12-06 2022-03-31 Alexion Pharmaceuticals, Inc. Anti-alk2 antibodies and uses thereof

Family Cites Families (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60253455A (ja) * 1984-05-28 1985-12-14 京セラ株式会社 骨形成因子を含有する生体材料とその製造方法
US4620327A (en) 1984-07-05 1986-11-04 Caplan Arnold I Process of adapting soluble bone protein for use in stimulating osteoinduction
US6432919B1 (en) † 1986-07-01 2002-08-13 Genetics Institute, Inc. Bone morphogenetic protein-3 and compositions
IL83003A (en) 1986-07-01 1995-07-31 Genetics Inst Factors that soak bone formation
US5013649A (en) 1986-07-01 1991-05-07 Genetics Institute, Inc. DNA sequences encoding osteoinductive products
NZ226170A (en) 1987-09-18 1990-07-26 Ethicon Inc Stable freeze-dried pharmaceutical composition containing epidermal growth factor
US4863732A (en) * 1987-12-16 1989-09-05 Collagen Corporation Injectable composition for inductive bone repair
US5011691A (en) 1988-08-15 1991-04-30 Stryker Corporation Osteogenic devices
US5266683A (en) 1988-04-08 1993-11-30 Stryker Corporation Osteogenic proteins
US5344654A (en) * 1988-04-08 1994-09-06 Stryker Corporation Prosthetic devices having enhanced osteogenic properties
US4968590A (en) 1988-04-08 1990-11-06 Stryker Corporation Osteogenic proteins and polypeptides
EP0429570B1 (fr) † 1989-03-28 1998-01-14 Genetics Institute, Inc. Compositions osteoinductrices
US5158934A (en) * 1989-09-01 1992-10-27 Genentech, Inc. Method of inducing bone growth using TGF-β
US5290558A (en) * 1989-09-21 1994-03-01 Osteotech, Inc. Flowable demineralized bone powder composition and its use in bone repair
US5290271A (en) * 1990-05-14 1994-03-01 Jernberg Gary R Surgical implant and method for controlled release of chemotherapeutic agents
ATE209251T1 (de) 1990-05-16 2001-12-15 Genetics Inst Knochen- und knorpel-bildung hervorrufende proteine
WO1992000382A1 (fr) 1990-06-15 1992-01-09 Carnegie Institution Of Washington Gdf-1
US5853746A (en) * 1991-01-31 1998-12-29 Robert Francis Shaw Methods and compositions for the treatment and repair of defects or lesions in cartilage or bone using functional barrier
US5674844A (en) * 1991-03-11 1997-10-07 Creative Biomolecules, Inc. Treatment to prevent loss of and/or increase bone mass in metabolic bone diseases
SK136693A3 (en) * 1991-06-05 1994-10-05 Procter & Gamble Therapeutic compositions for osteoinduction
US5693615A (en) * 1991-06-05 1997-12-02 The Procter & Gamble Company Therapeutic compositions for osteoinduction
KR100255415B1 (ko) 1991-06-25 2000-05-01 브루스 엠. 에이센 비엠피-9 조성물
US6287816B1 (en) 1991-06-25 2001-09-11 Genetics Institute, Inc. BMP-9 compositions
CA2116559C (fr) † 1991-08-30 2005-05-10 Thangavel Kuberasampath Traitement pour prevenir la perte de et/ou augmenter la masse osseuse des maladies metaboliques des os
US5192743A (en) † 1992-01-16 1993-03-09 Genentech, Inc. Reconstitutable lyophilized protein formulation
IL106278A0 (en) † 1992-07-13 1993-11-15 Sumitomo Metal Ind Bone formation-inducing protein
JPH08501779A (ja) † 1992-09-15 1996-02-27 クリエイティブ バイオモレキュルズ，インコーポレイテッド モルフォゲン誘導歯周組織再生
AU681362B2 (en) † 1992-11-03 1997-08-28 Stryker Corporation OP-3-induced morphogenesis
DE4240621A1 (de) 1992-12-03 1994-06-09 Zahnradfabrik Friedrichshafen Verfahren zur Steuerung und Regelung der Lastübernahme bei einem automatischen Schaltgetriebe
ATE153535T1 (de) † 1993-01-12 1997-06-15 Genentech Inc Tgf-beta zusammensetzung zum herbeiführen von knochenwachstum
EP1475440A3 (fr) 1993-01-12 2004-11-17 The Johns Hopkins University School Of Medicine Facteur-3 de croissance et de différentiation
CA2161807A1 (fr) 1993-05-12 1994-11-24 Anthony J. Celeste Compositions bmp-10
CA2165778A1 (fr) 1993-07-09 1995-01-19 Se-Jin Lee Facteur 7 de differentiation de la croissance
US5531791A (en) * 1993-07-23 1996-07-02 Bioscience Consultants Composition for repair of defects in osseous tissues, method of making, and prosthesis
WO1995006656A1 (fr) * 1993-09-03 1995-03-09 The Regents Of The University Of California Facteur et compositions agissant sur les tissus neuronaux
US5385887A (en) * 1993-09-10 1995-01-31 Genetics Institute, Inc. Formulations for delivery of osteogenic proteins
JPH09505991A (ja) 1993-10-08 1997-06-17 ザ ジョーンズ ホプキンス ユニバーシティー スクール オブ メディシン 増殖分化因子‐１０
ES2255059T3 (es) 1993-12-07 2006-06-16 Genetics Institute, Llc Bmp-12, bmp-13 y composiciones suyas inductoras de tendon.
JPH09506675A (ja) † 1993-12-14 1997-06-30 イー・アイ・デュポン・ドゥ・ヌムール・アンド・カンパニー 使用済み触媒の回収
US5906827A (en) 1994-06-03 1999-05-25 Creative Biomolecules, Inc. Matrix for the manufacture of autogenous replacement body parts
WO1996026737A1 (fr) † 1995-03-01 1996-09-06 Creative Biomolecules, Inc. Regeneration de la dentine induite par un morphogene
PL186518B1 (pl) † 1995-04-19 2004-01-30 Bioph Biotech Entw Pharm Gmbh Białko, kompozycja farmaceutyczna i sposób wytwarzania białka
FI952196A0 (fi) 1995-05-08 1995-05-08 Suomen Punainen Risti Veripalv Framstaellning av immunoglobulin
PT831884E (pt) * 1995-06-05 2003-11-28 New York Society Uso de proteinas morfogeneticas do caso para cicatrizacao e reparacao da ligacao do tecido conjuntivo
US5902785A (en) * 1995-06-06 1999-05-11 Genetics Institute, Inc. Cartilage induction by bone morphogenetic proteins
US5674292A (en) * 1995-06-07 1997-10-07 Stryker Corporation Terminally sterilized osteogenic devices and preparation thereof
JPH09143093A (ja) * 1995-11-17 1997-06-03 Hoechst Japan Ltd 軟骨・骨誘導性修復用材料
US6048964A (en) * 1995-12-12 2000-04-11 Stryker Corporation Compositions and therapeutic methods using morphogenic proteins and stimulatory factors
US5752974A (en) † 1995-12-18 1998-05-19 Collagen Corporation Injectable or implantable biomaterials for filling or blocking lumens and voids of the body
US5842477A (en) * 1996-02-21 1998-12-01 Advanced Tissue Sciences, Inc. Method for repairing cartilage
JP2002504083A (ja) † 1996-03-05 2002-02-05 オーケスト インコーポレイテッド ヒアルロン酸および増殖因子による骨の増殖を促進する方法
DE19647853A1 (de) † 1996-11-19 1998-05-20 Bioph Biotech Entw Pharm Gmbh Verbindungen mit verbesserter knorpel- und/oder knocheninduzierender Aktivität
EA001579B1 (ru) † 1997-01-30 2001-06-25 Хехст Марион Рассел Лтд. Лиофилизированная композиция морфогенетического фактора роста кости мр52 человека и способ её получения
ATE239514T1 (de) * 1997-02-07 2003-05-15 Stryker Corp Matrixlose osteogene vorrichtungen und implantate und verfahren zu deren verwendung
EP1370287A2 (fr) † 2000-12-01 2003-12-17 Wyeth Methode et composition permettant de moduler la croissance osseuse

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7902172B2 (en) 1996-03-05 2011-03-08 Depuy Spine, Inc. Method of promoting bone growth with hyaluronic acid and growth factors

Also Published As

Publication number Publication date
JP2009102393A (ja) 2009-05-14
JP5124495B2 (ja) 2013-01-23
CA2280931C (fr) 2009-05-05
DE69814352T3 (de) 2009-08-13
DE69814352D1 (de) 2003-06-12
WO1998034655A1 (fr) 1998-08-13
EP0957943A1 (fr) 1999-11-24
EP0957943B1 (fr) 2003-05-07
JP2001511042A (ja) 2001-08-07
US6426332B1 (en) 2002-07-30
EP1350525A2 (fr) 2003-10-08
US20020091077A1 (en) 2002-07-11
DE69814352T2 (de) 2004-03-25
JP4388602B2 (ja) 2009-12-24
EP1350525A3 (fr) 2003-12-10
ATE239514T1 (de) 2003-05-15
EP0957943B2 (fr) 2008-11-26
JP2012102145A (ja) 2012-05-31
EP2332564A1 (fr) 2011-06-15
AU6267798A (en) 1998-08-26
JP2015227366A (ja) 2015-12-17
US6281195B1 (en) 2001-08-28

Similar Documents

Publication Publication Date Title
CA2280931A1 (fr) Dispositif osteogeniques sans matrice, implants et methodes d'utilisation associees
AU8769198A (en) Maxillofacial anchoring system for alveolar and small bone skeletal distraction
CA2294686A1 (fr) Pate malleable servant a remplir les deficits osseux
AU4015597A (en) Process for producing bone cement containing active substances
CA2114462A1 (fr) Dispositif de revetement comportant une membrane de revetement
HU9400863D0 (en) Prosthesis between vertebrae and method for its implant
HK1012588A1 (en) Filling material for soft tissue implant prostheses and implants made therewith
ATE194275T1 (de) Zwischenwirbelkörper
AU2002323457A1 (en) Implant for partial disc and cancellous bone replacement
AU2798599A (en) Injectable implants for tissue augmentation and restoration
CA2386396A1 (fr) Implant en matiere osseuse
AU9215198A (en) Reverse phase connective tissue repair composition
ES2006980A6 (es) Un implante para las sustitucion de un diente o una parte del tejido oseo.
AU2116895A (en) Bone anchoring apparatus, in particular for dental applications
EP1514519A3 (fr) Greffes de fusion osseuse et intrumentation.
AU7574691A (en) Method and device for efficiently anchoring an implant, and method and device for promoting growth of bone tissue
AU7711794A (en) An implant
HUP9700926A3 (en) Vitamine d3 analogues, process for producing them and pharmaceutial compositions containing the same
FR2769827B1 (fr) Implant pour arthrodese rachidienne inter-somatique
GB9321700D0 (en) Bone implants
FR2717066B1 (fr) Implant osseux notamment pour pédicule de vertèbre.
EP1721617A3 (fr) Thérapeutiques dentaires comprenant de l'hormone parathyroide
AU632095B2 (en) Orthopaedic implant
GB2237564B (en) Filler for filling in defect of bone and region of osteoporosis
AU4468093A (en) Composition and methods for the generation of bone

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20170206